Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sonnet Biotherapeutics Holdings Inc
(NQ:
SONN
)
1.740
+0.040 (+2.35%)
Streaming Delayed Price
Updated: 12:05 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
9,227
Open
1.700
Bid (Size)
1.730 (3)
Ask (Size)
1.740 (1)
Prev. Close
1.700
Today's Range
1.700 - 1.750
52wk Range
1.080 - 26.40
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Sonnet BioTherapeutics to Present Preclinical Data on SON-080 for Chemotherapy-Induced Peripheral Neuropathy (CIPN) at the AACR 2024 Annual Meeting
March 19, 2024
Via
ACCESSWIRE
Sonnet BioTherapeutics Announces Early Safety Data from the Company’s Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Met the Study’s Initial Pre-Specified Objective
March 11, 2024
Via
ACCESSWIRE
Performance
YTD
-1.14%
-1.14%
1 Month
-23.01%
-23.01%
3 Month
+28.89%
+28.89%
6 Month
-29.55%
-29.55%
1 Year
-76.28%
-76.28%
More News
Read More
Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy Volunteers
February 29, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 14, 2024
Via
Benzinga
Sonnet BioTherapeutics Provides Fiscal Year 2023 Business Overview
October 31, 2023
Via
ACCESSWIRE
Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update
February 14, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 13, 2024
Via
Benzinga
Sonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor Immunotherapy
December 21, 2023
Via
ACCESSWIRE
Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update
December 14, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 28, 2023
Via
Benzinga
What's Happening With Sonnet BioTherapeutics (SONN) Shares?
October 26, 2023
Via
Benzinga
Dow Falls Over 100 Points; Alphabet Shares Tumble After Q3 Results
October 25, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 25, 2023
Via
Benzinga
Crude Oil Edges Higher; Thermo Fisher Scientific Cuts FY23 Forecast
October 25, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 25, 2023
Via
Benzinga
Why Sonnet BioTherapeutics (SONN) Stock Is Getting Hammered
October 25, 2023
Via
Benzinga
EVGO Stock Slips as TD Cowen Downgrades EVgo
October 25, 2023
Via
InvestorPlace
Nasdaq Down 1.5%; Microsoft Posts Upbeat Results
October 25, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 25, 2023
Via
Benzinga
Why Is InMed Pharmaceuticals (INM) Stock Down 25% Today?
October 25, 2023
Via
InvestorPlace
Why Is Sonnet BioTherapeutics (SONN) Stock Down 33% Today?
October 25, 2023
Via
InvestorPlace
Why Microsoft Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
October 25, 2023
Via
Benzinga
Sonnet BioTherapeutics Announces Pricing of $4.55 Million Underwritten Public Offering
October 25, 2023
Via
ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
October 25, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 24, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.